They keep trying. Maybe they'll get a slot for just very advanced fibrosis patients willing to tolerate the side effects. That would still be a profitable market for them. It would also possibly be a nice compliment to a "fat-buster" that doesn't do quite as much on the fibrosis side for advanced patients. Just nice to see the whole disease back in the headlines and not
...more